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Abstract: This study sought to understand the medication adherence and quality of life (QOL) of
recipients of a pharmacist-based medication management program among independently living older
adults. Using a cross-sectional, quasi-experimental study design, we compared older adults enrolled
in the program to older adults not enrolled in the program. Data were collected via face-to-face
interviews in independent-living facilities and in participants’ homes. Independently living older
adults who were enrolled in the medication management program (n = 38) were compared to older
adults not enrolled in the program (control group (n = 41)). All participants were asked to complete
questionnaires on health-related quality of life (QOL, using the SF-36) and medication adherence
(using the four-item Morisky scale). The medication management program recipients reported
significantly more prescribed medications (p < 0.0001) and were more likely to report living alone
(p = 0.01) than the control group. The medication management program recipients had a significantly
lower SF-36 physical functioning score (p = 0.03) compared to the control group, although other SF-36
domains and self-reported medication adherence were similar between the groups. Despite taking
more medications and more commonly living alone, independent living older adults enrolled in
a pharmacist-based medication management program had similar QOL and self-reported medication
adherence when compared to older adults not enrolled in the program. This study provides initial
evidence for the characteristics of older adults receiving a pharmacist-based medication management
program, which may contribute to prolonged independent living and positive health outcomes.
Keywords: pharmacist roles; adherence; older adults; medication management; quality of life;
medication use

1. Introduction
Community pharmacists generally see patients with chronic medical conditions at least monthly,
at the time medications are refilled. This regular interaction places pharmacists in a unique
position to monitor and manage medications for older adults. Furthermore, extensive training in
pharmacotherapy and patient communication uniquely prepares pharmacists to play a vital role
in minimizing medication-related problems. Pharmacist interventions can improve patient drug
Pharmacy 2017, 5, 20; doi:10.3390/pharmacy5020020
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knowledge and adherence [1]; however, little is known about the population that participates in
pharmacist interventions, and this is especially true in the older adult population.
A systematic review evaluating pharmacist interventions to optimize medication use in nursing
home settings provided equivocal results [2]. Reviews assessing pharmacist interventions with
older patients to improve health outcomes, QOL, adherence, and cost-effective care also provide
mixed findings and suggest further research is needed [3,4]. Despite findings from these systematic
reviews, it is clear that regular interaction and medication management provide pharmacists with the
opportunity to circumvent many drug therapy problems in older adults, thereby easing patient, family,
and caregiver burden. Drug therapy problems can be categorized into seven areas: unnecessary drug
therapy, need of additional drug therapy, ineffective drug therapy, too low a dosage, too high a dosage,
adverse drug reactions, and non-compliance [5]. Polypharmacy and drug therapy problems have
been linked with poor health outcomes. For example, patients who have more medications in their
home are more likely to have increased severity of their illnesses and are at higher risk for therapeutic
duplications [6].
Humanistic parameters, such as quality of life, have been evaluated as predictors of outcomes in
the older population. Health-related quality of life surveys, such as the Short Form (SF)-12 and SF-36,
have been shown to be independent predictors of hospitalization and mortality [7]. These self-reported
surveys provide specific feedback on patients’ physical and mental performance; a decline in these
performances has been linked to a change in health status and predicts future adverse events [8].
Medication non-adherence has also been associated with poor health outcomes including
disease progression and increased costs [9]. Research has demonstrated that a comprehensive
program provided by pharmacists, including blister-packed medications, is associated with substantial
improvements in medication adherence among older adults resulting in meaningful improvements in
health [10]. Estimates of non-adherence in the older adult vary from 40% to 75%, and there are still
many unanswered questions as to the most effective pharmacist-based intervention for promoting
medication adherence [11].
Unfortunately, a non-invasive “gold standard” for measuring adherence is unavailable. A recent
study in the United Kingdom compared three common methods for measuring adherence (electronic
monitoring, pill counts, and self-report) in older adults and found substantial differences between
the three methods. The use of pill counts and self-reported surveys tended to correlate better with
adherence rates than prescription-bottle caps equipped with an electronic monitor that recorded when
the bottles were opened. However, the inconsistency with the electronic record in the study has been
postulated to be related to the varying patterns of bottle opening versus the number of pills taken
out [12].
The objective of this study was to understand the medication adherence and quality of life of
recipients that participate in a pharmacist-based medication management program. The ultimate goal
of the service described in this study is to prolong independent living and improve overall health
status for older adults.
2. Materials and Methods
2.1. Description of the Pharmacist-Based Medication Management Service
The pharmacist-based medication management program studied was developed specifically for
independently living older adults residing either in independent living facilities or within their own
home. The program is offered by a local community pharmacy. The program origins date back to the
late 1980s, when a former consultant pharmacist observed that patients residing in independent and
assisted living beds at a Central Kentucky nursing facility would benefit from pharmacist consultations
and adherence-based services. Originally, services were only offered to residents at that one facility;
however, over time, the program grew to include patients living in other facilities, and patients
living in their own homes. The program was designed to allow a pharmacist to manage, monitor,
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and optimize medication therapy with the goal of prolonging independent living in the older patient.
A key component of the program is the direct, individualized care and time devoted to each patient.
Patients are referred to the program from a variety of sources ranging from self-referral to healthcare
practitioner recommendation. Patients or caregivers, as well as practitioners, most often learn of the
service through word-of-mouth marketing or through previous experience with the service and call
the pharmacy themselves to initiate the enrollment process. Most often, these referrals are precipitated
by an adverse medication event or hospitalization.
The pharmacist-based medication management program consists of three primary components:
assessment, prescription organization, and weekly support/medication dispensing. When the
patient is first enrolled, initial home-based assessments are conducted to obtain baseline information
for the pharmacist to better understand the patient’s specific needs. These assessments include
demographic information, medication comprehension, cognitive assessments, and fall-risk assessments.
This information is documented in a chart that is kept in the pharmacy, and information is updated
after each weekly visit. Once the patient is enrolled into the program, all of their prescription and
non-prescription medications are organized, stored at the pharmacy, and managed by a clinical
pharmacist. Each week, a 7-day supply of the patient’s routine medications is prepared and delivered
to the patient’s home by a pharmacy technician or pharmacist. The patient’s routine medications are
dispensed in a weekly medication organizer; “as needed” medications are maintained separately.
Refills are also managed through the medication management service. The pharmacist obtains
prescriber authorization for refills prior to the supply of medication being depleted. If the patient
has a change in a medication (for example, an increase or decrease in dose) or is started on a new
medication during the week, the pharmacist on-call will be notified to dispense the medication and
update the medication organizer for the patient.
During the weekly visit, the pharmacist reviews the previous week’s medication organizer for
missed doses and documents each missed dose in the patient’s chart. The pharmacist follows up
with the patient or caregiver regarding patterns for missed doses and intervenes as appropriate.
The pharmacist also monitors patients for other medication-related problems including adverse drug
reactions, drug–drug interactions, and falls.
Other services provided to each patient include counseling on all new or changed prescription
orders, ensuring the weekly medication organizers are stored in appropriate areas of the home,
an up-to-date medication list, and ongoing medication review. The clinical pharmacist is on-call
24 h per day and maintains a constant line of communication between the prescriber, the patient,
and caregivers.
2.2. Study Design and Population
To understand the recipients of the pharmacist-based medication management program
a cross-sectional, quasi-experimental study of independently living older adults residing in central
Kentucky was conducted during January and February of 2011. The study included the program
recipients (intervention group), consisting of patients currently enrolled in the pharmacist-based
medication management program, and a control group that was recruited for comparison. Intervention
patients resided within their own home, or within independent-living facilities. The control group,
living in a similar situation as the intervention group, was recruited from independently living
older adults residing at three independent living facilities in the same central Kentucky town.
Participants over the age of 60 and living independently were eligible for inclusion. Exclusion criteria
were severe cognitive impairment (indicated by a lack of understanding of the research design and
purpose of their participation) and an inability to read or write English fluently.
The control group was recruited at three independent-living facilities in central Kentucky using
flyers approved by the University of Kentucky Institutional Review Board. Control participants were
asked to attend a group session for participation. The group session consisted of a description of
the research, an explanation of why the participants were being asked to participate, and completion
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of the questionnaires. Group sessions lasted approximately 20 min. Participants were asked to
complete demographic, medication adherence, and quality of life measurements. The control group
completed their questionnaires and returned them to the primary investigator at the end of the live
2017, 5, 20 participants were interviewed on an individual basis in their homes.
4 of
9 study
session.Pharmacy
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All
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prior
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end of the live session. Intervention participants were interviewed on an individual basis in their
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3. Results
3. Results
3.1. Subjects
3.1. Subjects A total of 79 independently living older adults participated in the study. Figure 2 shows the
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(78.9% vs. 48.8% in the control group, p = 0.01), and had a significantly higher annual household
income (p = 0.001).
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Table 1. Characteristics of the intervention and control groups.
Intervention
Group (n = 38)

Pharmacy 2017, 5, 20

Control Group 6 of 9p
(n = 41)
Value

Median
Age (IQR) of the intervention and control
87 (83–89)
84 (77–88)
0.07
Table
1. Characteristics
groups.
Sex, Females (%)
29 (76.3%)
27 (65.9%)
0.45
Intervention
Control
p
Highest level of education
Group (n = 38) Group (n = 41)
Value
SomeAge
college
or less
21 (55.3%)84 (77–88)
15 (36.6%)
0.22
Median
(IQR)
87 (83–89)
0.07
Sex,
Females
(%)
29
(76.3%)
27
(65.9%)
0.45
Bachelor’s degree or equivalent
9 (23.7%)
16 (39.0%)
Highest level of education
Masters degree or higher
8 (21.0%)
10 (24.4%)
Some college or less
21 (55.3%)
15 (36.6%)
0.22
Median number
of regularly
medications (including9 (23.7%)
Bachelor’s
degreescheduled
or equivalent
10 (8–13) 16 (39.0%)5 (4–8)
<0.0001
prescription, over-the-counter, and herbal products) (IQR)
Masters degree or higher
8 (21.0%)
10 (24.4%)
Median
ofscheduled
disease states
(IQR)
3.5 (2–5)
3 (2–5)
0.17
Median number
ofnumber
regularly
medications
reading
due to vision
14 (36.8%) 5 (4–8) 11 (26.8%)
(includingTrouble
prescription,
over‐the‐counter,
10 (8–13)
<0.0001 0.34
and herbal
products)
(IQR)
Number of subjects
with
at least one
hospital or emergency
16 (42.1%) 3 (2–5) 15 (36.6%)
0.62
Mediandepartment
number of visit
disease
states
(IQR)
3.5 (2–5)
0.17
in past
6 months
Trouble
reading
due toorvision
11 (26.8%)
0.34
Median number
of visits
to hospital
emergency department 14
in (36.8%)
1.5 (1–2.5)
1 (1–2)
0.20
Numberpast
of subjects
with
at
least
one
hospital
or
6 months (if greater than zero) (IQR)
16 (42.1%)
15 (36.6%)
0.62
emergency department visit in past 6 months
Number of subjects with at least one fall in past 6 months
13 (34.2%)
14 (34.1%)
>0.90
Median number of visits to hospital or emergency
1.5
(1–2.5)
1
(1–2)
0.20
Median number
of falls
in past (if
6 months
greater
than
zero) (IQR)
1 (1–3)
1 (1–2)
0.50
department
in past
6 months
greater(ifthan
zero)
(IQR)
Duration
of
time
in
current
home
Number of subjects with at least
13 (34.2%)
14 (34.1%)
>0.90
one fall in0–12
past months
6 months
11 (28.9%)
8 (19.5%)
0.33
Median number of falls in past
1–3 years
10
(26.3%)
17
(41.5%)
1 (1–3)
1 (1–2)
0.50
6 months (if greater than zero) (IQR)
4
or
more
years
17
(44.7%)
16
(39%)
Duration of time in current home
Number of people
living in current household
0–12 months
11 (28.9%)
8 (19.5%)
0.33
1–3 years
10 (26.3%)
1 person
30 (78.9%)17 (41.5%)
20 (48.8%)
0.01
4 or more
years
17
(44.7%)
16
(39%)
2 persons
8 (21.1%)
21 (51.2%)
Number of people living in current household
Annual household income
1 person
30 (78.9%)
20 (48.8%)
0.01
0–$25,000
12 (29.2%)
2 persons
8 (21.1%)8 (21.1%) 21 (51.2%)

Annual household
income
$25,001–$50,000
0–$25,000
$50,001–$100,000
$25,001–$50,000
Greater than $100,000
$50,001–$100,000
Not specified
Greater than
$100,000
Not specified

6 (15.7%)
17 (41.5%)
0.0014
8 (21.1%)3 (7.9%) 12 (29.2%)
8 (19.5%)
6 (15.7%)
17 (41.5%)
0.0014
13 (34.2%)
2 (4.9%)
3 (7.9%)
8 (19.5%)
8 (21.1%) 2 (4.9%) 2 (4.9%)
13 (34.2%)
8 (21.1%)
2 (4.9%)

3.2. Medication Adherence
3.2. Medication Adherence

In the intervention group, 60.5% reported a high adherence rate, while 43.9% of the control group
In the
intervention
group,
60.5% the
reported
a high adherence
while
43.9%
of the3),control
reported
a high
adherence
rate using
self-reported
four-item rate,
Morisky
Scale
(Figure
although the
group reported a high adherence rate using the self‐reported four‐item Morisky Scale (Figure 3),
difference was not statistically significant (p = 0.21). The intervention group had a median objective
although the difference was not statistically significant (p = 0.21). The intervention group had a
medical chart adherence rate of 99% (range of 88% to 100%) during the six-week retrospective chart
median objective medical chart adherence rate of 99% (range of 88% to 100%) during the six‐week
review
(Table 2).
retrospective chart review (Table 2).

Figure
3. Adherence.
Figure
3. Adherence.
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Table 2. Six-week objective medication adherence rate (%) for the intervention group (n = 33) *.
Mean (SD)

98 (0.03)

Median (Range)

99 (88–100)

* Five subjects were excluded from the retrospective chart review due to lack of six-week adherence information.

3.3. Quality of Life
With the exception of PF, there was no difference between the two groups in the eight domains
of the SF-36 (Table 3). The intervention group had a significantly lower median PF compared to the
control group (p = 0.03).
Table 3. SF-36v2 norm-based scores.

Physical Component Summary (PCS)
Mental Component Summary (MCS)
Physical Functioning (PF)
Role-Physical (RP)
Bodily Pain (BP)
General Health (GH)
Vitality (VT)
Social Functioning (SF)
Role Emotional (RE)
Mental Health (MH)

Intervention (n = 38)

Control (n = 41)

p Value

41.77 (11.31)
55.85 (48.34–59.76)
36.49 (26.92–47.97)
39.19 (32.46–54.91)
51.51 (42.64–62.00)
53.19 (43.68–57.94)
52.60 (40.72–55.57)
54.84 (37.27–57.34)
54.43 (38.76–56.17)
53.48 (48.25–58.72)

45.37 (8.80)
54.67 (50.12–60.17)
46.06 (38.40–49.89)
45.93 (39.19–52.66)
50.71 (42.64–55.55)
53.19 (46.05–55.56)
52.60 (49.63–58.54)
52.33 (47.31–57.34)
52.69 (42.24–56.17)
56.10 (53.48–58.72)

0.12
0.97
0.03
0.06
0.69
0.97
0.15
0.64
0.97
0.36

Data are expressed as median (with IQR) except PCS, which is reported with mean and standard deviation; p-values
were based on non-parametric analyses except PCS, for which a two-sample t-test was appropriate.

4. Discussion
This evaluation of medication adherence and quality of life for independently living older adults
participating in a pharmacist-based medication management program found that participants had
similar QOL and self-reported medication adherence when compared to independent-living older
adults not enrolled in the program, despite participants taking more prescribed medications and
more commonly living alone. As previously described, medication adherence and quality of life have
been shown to predict health outcomes in the older adult [1,6–11]. Adverse health outcomes result
in a functional decline and a loss of independence in older adults. Interventions to improve health
outcomes may reduce the risk of this loss [15,16]. Study findings demonstrate that various levels
of independent living exist in the older population. It is concluded that assumptions about patient
ability to manage their medications based on their level of relative “independence” should be made
cautiously in the health care community.
In this study of independently living older adults, findings indicated that medication management
program recipients reported being prescribed significantly more medications and were more likely to
live alone. From the literature, it is well understood that taking more medications can add to the frailty
and poor health outcomes of older adults. Moreover, living alone has been shown to be an independent
predictor of frailty and decline in activities of daily living in older patients [17].
The physical functioning was significantly lower in the pharmacy program recipients,
indicating a lower functionality level of independent living. All other QOL indicators were similar
between the two groups. Thus, medication management program recipients have relatively similar
QOL compared to other independently living older adults, but are prescribed more medications and
have lower levels of physical functioning.
Literature documents the strong positive correlation between high rates of medication adherence
and positive health outcomes [9,10,18–20]. Although this study did not find a difference in self-reported
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medication adherence, the pharmacy program participants had a documented chart medication
adherence rate exceeding 90%.
As stated previously, patients are referred to medication management programs from a variety
of sources, often as a result of an adverse medication event or hospitalization. Early implementation
of an effective pharmacist-based medication management program could help address adverse
medication-related issues and potentially prolong independent living. To improve care for the
independently living older adult, it is essential to recognize the negative outcomes of suboptimal
medication management. Although not directly assessed in this study, prolonged independence
for the older adult reduces overall healthcare costs by preventing or delaying institutionalization.
The findings of this study suggest that further evaluation of pharmacist-based medication management
programs for older adults is warranted to assess potential causal relationships as well as patient, family,
and caregiver perceived value of such programs. Healthcare providers should be more proactive
in identifying older adults who require assistance with managing their medications and refer to
pharmacists who specialize in comprehensive medication management to maintain independent living
among this population.
One important limitation of this study was the difference in the recruitment process between
the two groups. Participants in the intervention group were already enrolled in the medication
management program possibly because they were at a higher risk for losing their independence.
The research session was conducted in their home during a regular medication management program
visit due to feasibility of administering the surveys. Participants in the control group attended
a live session outside their home producing a different environment for completing the research
questionnaires. Another limitation of the study was the cross-sectional design, which evaluated
a snapshot of self-reported adherence and quality of life. Lack of baseline measures for program
participants precludes an assessment of impact. Future research should study participants over time
to evaluate the true impact of the medication management program on medication adherence and
quality of life using a longitudinal, clinical trial design.
5. Conclusions
This study provides initial evidence for characterizing older adults receiving a pharmacist-based
medication management program. Individuals enrolled in the medication management program
had comparable quality of life and self-reported adherence to control participants, even though the
program recipients were taking more medications and were more likely to live alone.
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